DXCM 69.55 (-0.5%)
US2521311074Medical Diagnostics & ResearchDiagnostics & Research

DexCom (DXCM) Competitor Comparison

We are evaluating the key criteria listed to compare DexCom (DXCM) against its competitors in the Diagnostics & Research industry.

Performance 5 years - DXCM ranking 12 / 58

These are the competitors of DexCom in the industry Diagnostics & Research ranked by performance 5 years
1. Lantheus Holdings LNTH
492.66
2. RadNet RDNT
377.58
3. Medpace Holdings MEDP
339.61
4. Natera NTRA
258
5. Meridian Bioscience VIVO
118.46
6. Danaher DHR
117.57
7. Mettler-Toledo MTD
113.03
8. Thermo Fisher Scientific TMO
108.96
9. Icon ICLR
107.22
10. Twist Bioscience TWST
94.87
11. Agilent Technologies A
90.36
12. DexCom DXCM
76.38
13. Fulgent Genetics FLGT
73.88
14. IDEXX Laboratories IDXX
72.32
15. Waters WAT
66.34
16. Qiagen QGEN
63.21
17. DarioHealth DRIO
61.4
18. IQVIA Holdings IQV
56.25
19. Laboratory Corp of America Holdings LH
51.82
20. PerkinElmer PKI
48.44
21. Charles River Laboratories CRL
45.57
22. Quest Diagnostics DGX
43.1
23. Co-Diagnostics CODX
17.43
24. Ortho Clinical Diagnostics Holdings OCDX
13.74
25. Heska HSKA
12.14
26. CareDx CDNA
11.3
27. Syneos Health SYNH
-16.98
28. Myriad Genetics MYGN
-17.62
29. Anixa Biosciences ANIX
-18.43
30. Bioventus BVS
-19.67
31. Exact Sciences EXAS
-22.38
32. Olink Holding OLK
-26.82
33. NeoGenomics NEO
-31.84
34. Sotera Health SHC
-43.26
35. Illumina ILMN
-50.52
36. Inotiv NOTV
-50.54
37. Sera Prognostics SERA
-53.36
38. Neogen NEOG
-54.52
39. Trinity Biotech TRIB
-57.89
40. Personalis PSNL
-58.91
41. Pacific Biosciences of California PACB
-61.18
42. Guardant Health GH
-65.1
43. National Research NRC
-67.69
44. Enzo Biochem ENZ
-67.71
45. Psychemedics PMD
-74.84
46. Interpace Biosciences IDXG
-75.88
47. MaxCyte MXCT
-77.16
48. bioAffinity Technologies BIAF
-77.26
49. Exagen XGN
-80.13
50. MDxHealth MDXH
-83.54
51. Global Cord Blood CO
-86.47
52. Precipio PRPO
-86.51
53. Biodesix BDSX
-87.56
54. Neuronetics STIM
-92.42
55. Aspira Womens Health AWH
-92.98
56. Organovo Holdings ONVO
-95.1
57. SeqLL SQL
-95.22
58. Prenetics Global PRE
-96.41

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.